-transparent.png){kind=logo}
Medullary thyroid carcinoma associated diarrhoea can be disabling. A 75-yr-old man with metastatic medullary thyroid carcinoma and refractory diarrhoea is described. Subcutaneous administration of the somatostatin analogue, octreotide, 100 micrograms thrice daily, resulted in a sustained improvement in diarrhoea and disappearance of faecal incontinence without reducing calcitonin levels. Octreotide therapy should be considered as symptomatic treatment for otherwise refractory diarrhoea associated with medullary thyroid carcinoma.
Related Publications
W M Smid, and
R P Dullaart
December 1969,
Gut,
W M Smid, and
R P Dullaart
January 1969,
Scandinavian journal of gastroenterology,
W M Smid, and
R P Dullaart
May 1981,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
W M Smid, and
R P Dullaart
January 1969,
Duodecim; laaketieteellinen aikakauskirja,
W M Smid, and
R P Dullaart
January 1968,
Folia medica Neerlandica,
W M Smid, and
R P Dullaart
December 1968,
Gut,
W M Smid, and
R P Dullaart
July 1979,
Gut,
W M Smid, and
R P Dullaart
January 1993,
Hormone and metabolic research. Supplement series,
W M Smid, and
R P Dullaart
June 1996,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
W M Smid, and
R P Dullaart
January 1968,
Duodecim; laaketieteellinen aikakauskirja,
